Fiona Carr

682 total citations
12 papers, 217 citations indexed

About

Fiona Carr is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Physiology. According to data from OpenAlex, Fiona Carr has authored 12 papers receiving a total of 217 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Endocrinology, Diabetes and Metabolism, 4 papers in Surgery and 4 papers in Physiology. Recurrent topics in Fiona Carr's work include Asthma and respiratory diseases (3 papers), Lipoproteins and Cardiovascular Health (3 papers) and Diabetes Treatment and Management (2 papers). Fiona Carr is often cited by papers focused on Asthma and respiratory diseases (3 papers), Lipoproteins and Cardiovascular Health (3 papers) and Diabetes Treatment and Management (2 papers). Fiona Carr collaborates with scholars based in United Kingdom, Netherlands and United States. Fiona Carr's co-authors include Ewan R. Pearson, Roger Tavendale, Graham Leese, Louise A. Donnelly, Andrew D. Morris, Alex S. F. Doney, Kaixin Zhou, Adem Y. Dawed, Moneeza K. Siddiqui and Gwen Kennedy and has published in prestigious journals such as Nature Medicine, Nature reviews. Neuroscience and PLoS ONE.

In The Last Decade

Fiona Carr

12 papers receiving 217 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fiona Carr United Kingdom 7 94 91 74 41 32 12 217
Hisamoto Kuroda Japan 7 117 1.2× 57 0.6× 29 0.4× 76 1.9× 21 0.7× 16 348
Eszter Berta Hungary 10 116 1.2× 63 0.7× 16 0.2× 32 0.8× 23 0.7× 28 245
Jasna Klen Slovenia 10 131 1.4× 80 0.9× 23 0.3× 103 2.5× 22 0.7× 21 250
Danfeng Peng China 13 102 1.1× 99 1.1× 90 1.2× 115 2.8× 90 2.8× 36 416
Mozhgan Dorkhan Sweden 13 164 1.7× 53 0.6× 93 1.3× 63 1.5× 32 1.0× 22 326
Letizia Zeni Italy 6 52 0.6× 34 0.4× 31 0.4× 85 2.1× 15 0.5× 14 275
Sounnia Médiène-Benchekor Algeria 8 67 0.7× 34 0.4× 53 0.7× 42 1.0× 34 1.1× 21 186
Genevieve M Leyden United Kingdom 6 33 0.4× 44 0.5× 89 1.2× 59 1.4× 32 1.0× 8 215
V. Médeau France 6 217 2.3× 150 1.6× 42 0.6× 73 1.8× 28 0.9× 9 304
Zhi Luo China 10 42 0.4× 94 1.0× 42 0.6× 110 2.7× 32 1.0× 28 333

Countries citing papers authored by Fiona Carr

Since Specialization
Citations

This map shows the geographic impact of Fiona Carr's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fiona Carr with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fiona Carr more than expected).

Fields of papers citing papers by Fiona Carr

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fiona Carr. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fiona Carr. The network helps show where Fiona Carr may publish in the future.

Co-authorship network of co-authors of Fiona Carr

This figure shows the co-authorship network connecting the top 25 collaborators of Fiona Carr. A scholar is included among the top collaborators of Fiona Carr based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fiona Carr. Fiona Carr is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Gaur, Akshay, Fiona Carr, & David Warriner. (2024). Cardiogeriatrics: the current state of the art. Heart. 110(14). 933–939. 7 indexed citations
2.
Maroteau, Cyrielle, Esther Herrera‐Luis, Sundararajan Srinivasan, et al.. (2021). LTA4H rs2660845 association with montelukast response in early and late-onset asthma. PLoS ONE. 16(9). e0257396–e0257396. 6 indexed citations
3.
Siddiqui, Moneeza K., Gillian Smith, Pamela St. Jean, et al.. (2021). Diabetes status modifies the long-term effect of lipoprotein-associated phospholipase A2 on major coronary events. Diabetologia. 65(1). 101–112. 6 indexed citations
4.
McDonald, Timothy J., Femke Rutters, Louise A. Donnelly, et al.. (2018). A Type 1 Diabetes Genetic Risk Score Can Identify Patients With GAD65 Autoantibody–Positive Type 2 Diabetes Who Rapidly Progress to Insulin Therapy. Diabetes Care. 42(2). 208–214. 38 indexed citations
5.
Siddiqui, Moneeza K., Gwen Kennedy, Fiona Carr, et al.. (2018). Lp-PLA2 activity is associated with increased risk of diabetic retinopathy: a longitudinal disease progression study. Diabetologia. 61(6). 1344–1353. 32 indexed citations
6.
Siddiqui, Moneeza K., Abirami Veluchamy, Cyrielle Maroteau, et al.. (2017). CKM Glu83Gly Is Associated With Blunted Creatine Kinase Variation, but Not With Myalgia. Circulation Cardiovascular Genetics. 10(4). 3 indexed citations
7.
Hébert, Harry L., Keith Milburn, Abirami Veluchamy, et al.. (2017). Cohort Profile: Genetics of Diabetes Audit and Research in Tayside Scotland (GoDARTS). International Journal of Epidemiology. 47(2). 380–381j. 56 indexed citations
8.
Dawed, Adem Y., Louise A. Donnelly, Roger Tavendale, et al.. (2016). CYP2C8andSLCO1B1Variants and Therapeutic Response to Thiazolidinediones in Patients With Type 2 Diabetes. Diabetes Care. 39(11). 1902–1908. 45 indexed citations
9.
Carr, Fiona. (2015). Adding insult to allergy. Nature Reviews Drug Discovery. 14(8). 528–528. 1 indexed citations
10.
Carr, Fiona. (2015). Adding insult to allergy. Nature reviews. Neuroscience. 16(8). 444–444. 1 indexed citations
11.
Carr, Fiona. (2014). Metabolic syndrome: Sweeteners and glucose intolerance. Nature Medicine. 20(10). 1105–1105. 1 indexed citations
12.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hisamoto Kuroda Breakdown of academic impact, for papers by Eszter Berta Breakdown of academic impact, for papers by Jasna Klen Breakdown of academic impact, for papers by Danfeng Peng Breakdown of academic impact, for papers by Mozhgan Dorkhan Breakdown of academic impact, for papers by Letizia Zeni Breakdown of academic impact, for papers by Sounnia Médiène-Benchekor Breakdown of academic impact, for papers by Genevieve M Leyden Breakdown of academic impact, for papers by V. Médeau Breakdown of academic impact, for papers by Zhi Luo
Rankless by CCL
2026